Clsics

Looking at the performance of Clsics in California, a few interesting trends emerge. In the Concentrates category, the brand has seen a slight decline over the months, moving from rank 28 in August to 31 in November. This indicates that although they were not in the top 20, they were still a significant player in the market. Their sales also reflect this trend, with a notable decrease from August to November. However, in the Edibles category, Clsics maintained a stable position, consistently ranking at 11 from August to October, and only slightly dropping to 12 in November. This shows a strong performance in this category, consistently staying within the top 20 brands.

On the other hand, in the Pre-Roll category, Clsics remained outside the top 20, with rankings hovering around the 42-43 range over the four-month period. Despite not being in the top 20, their sales figures remained relatively stable, indicating a steady consumer base. The Vapor Pens category shows a similar pattern, with Clsics ranking outside of the top 20. However, there is a slight improvement, as they moved up from rank 100 in August to 96 in November. Sales in this category also decreased over time, suggesting a need for the brand to re-strategize in this area. Overall, while Clsics shows strong performance in some categories, there is room for improvement in others.

In the California Edibles market, Clsics has been maintaining a steady position, ranking 11th in August, September, and October of 2023, and slipping slightly to 12th in November. This is in contrast to STIIIZY which has shown a steady upward trend, moving from 14th to 11th over the same period. Dr. Norm's, a direct competitor, has seen a slight decrease in rank, moving from 12th to 14th. Emerald Sky has consistently held the 10th spot, indicating stable sales, while Drops has fluctuated between 13th and 17th. In terms of sales, Clsics has seen a slight decrease over the period, while STIIIZY has seen a significant increase, indicating a potential shift in consumer preference. However, Clsics still maintains a higher rank and presumably higher sales than Drops, despite Drops' upward trend in rank.

In November 2023, the top-performing product from Clsics was the Dark Side Of The Berry Live Rosin Gummies 10-Pack (100mg), climbing from the second spot to first with sales of 5893 units. The CBN:THC 4:1 Midnight Cereal Rosin Gummies 10-Pack, which had consistently held the top spot, dropped to the second position. The third and fourth positions were held by Clockwork Lemon Rosin Gummies 10-Pack (100mg) and Blackberry Fire Live Rosin Gummies 10-Pack (100mg) respectively, maintaining their ranks from the previous month. The least performing product was the Call Of Focus Sour Limeade Loadout Rosin Gummies 10-Pack (100mg), which consistently held the fifth position over the past four months. This analysis shows a significant shift in customer preference towards the Dark Side Of The Berry Live Rosin Gummies 10-Pack (100mg).